Brief: Chimeric Therapeutics Says To Return Chlorotoxin (CHM CLTX) Car T-Cell Therapy Asset
27/02/2026 02:04
Feb 27 (Reuters) - Chimeric Therapeutics Ltd CHM.AX: TO RETURN TO CITY OF HOPE CHLOROTOXIN (CHM CLTX) CAR T-CELL THERAPY ASSET THAT CO HAD EXCLUSIVELY LICENSED Further company coverage: CHM.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chimeric Therapeutics
See all newsBrief: Chimeric Therapeutics Says Phillip Hains Appointed Interim Chairman
Brief: Chimeric Therapeutics Posts Prelim Loss For Year Of A$18.8 MLN
Brief: Chimeric Therapeutics Intends To Enter Negotiations With Its Creditors
Brief: Chimeric Therapeutics Seeks Trading Halt
Australia's Chimeric Therapeutics rises on positive data for its cell therapy clinical trial